paclitaxel
Phase 2- Indications
- Ovarian cancer, Prostate cancer, Pancreatic cancer, Pancreatic mucinous cysts
Company intelligence / Profile preview
CritiTech provides contract development and manufacturing services to pharmaceutical companies, specializing in particle engineering to improve solubility, bioavailability, and delivery of drugs—including cytotoxic compounds and inhaled formulations. It uses proprietary technologies such as Purcision™ supercritical precipitation alongside established methods like spray drying. The company works with both early-stage biotech firms and major pharmaceutical companies to support drug development from proof-of-concept through Phase III cGMP production.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CritiTech Particle Engineering Solutions.